Our mission - is to facilitate the transition of the Russian pharmaceutical market to develop into mature, be a guide on the course of development of the potential of all the pharmaceutical market participants, thereby improving the quality of life for the end user and society in general. Despite the relatively high susceptibility to Russia's external economic and financial risks, imbalances in the domestic policy and great social disparities, the pharmaceutical market in Russia has had a stable positive growth for the last few years.
April 17, 2018 in Moscow will be IX Forum of Russian regions: health.
The forum is held with the organizational support of the Federation Council of the Russian Federation, as well as with the participation of the State Duma of the Russian Federation and the Ministry of Health of the Russian Federation.
The Federal Antimonopoly Service (FAS) has submitted to the Government of the Russian Federation a document that authorizes the release of analogues of imported medicines without agreement with the patent holder in case of major threats to the health of citizens, TASS reports referring to the press service of the department.
The XII National Congress with international participation "Development of Pharmacoeconomy and Pharmacoepidemiology in the Russian Federation" "FarmakoEkonomika 2018" will take place on March 26-27, 2018 in Tyumen.
The Ministry of Health of Russia expects that the coverage of the population of the Russian Federation in the treatment of drugs in 2018 will be able to expand by at least 7-10% at the expense of the funds saved from the decrease in prices for medicines after the introduction of a centralized automated system of public procurement of medicines. This was stated by the head of the department Veronika Skvortsova at a meeting that President Vladimir Putin conducts with government members.
The Ministry of Health is adjusting the list of requirements for medical organizations conducting clinical trials of medical devices. Put up for public discussion a draft order of the Ministry of Health of the Russian Federation "On Amending the Order of the Russian Ministry of Health on May 16, 2013 number 300H" On approval of requirements for medical institutions conducting clinical trials of medical devices, and the procedure for establishing compliance with the medical organizations that requirements ".
The situation with regard to the protection of intellectual property rights in relation to medicines in our country has become paradoxical. Details in the material of Irina Sheykh, Director for Legal Affairs and Communications of AIPM, for "Rossiyskaya Gazeta".
We invite you to participate in the 4thInternational Conference ‘Clinical Research in Russia and in the Eurasian Economic Union’, organized by theBravo Business Forums. The event will take place onMarch 26-28in Moscow.